- Home
- CHCO vs SLNO Comparison
CHCO vs SLNO Comparison
Compare CHCO & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHCO
- SLNO
- Stock Information
- Founded
- CHCO 1957
- SLNO 1999
- Country
- CHCO United States
- SLNO United States
- Employees
- CHCO N/A
- SLNO N/A
- Industry
- CHCO Major Banks
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CHCO Finance
- SLNO Health Care
- Exchange
- CHCO Nasdaq
- SLNO Nasdaq
- Market Cap
- CHCO 1.7B
- SLNO 1.9B
- IPO Year
- CHCO N/A
- SLNO 2014
- Fundamental
- Price
- CHCO $119.68
- SLNO $46.88
- Analyst Decision
- CHCO Hold
- SLNO Strong Buy
- Analyst Count
- CHCO 4
- SLNO 6
- Target Price
- CHCO $117.25
- SLNO $74.83
- AVG Volume (30 Days)
- CHCO 71.3K
- SLNO 567.7K
- Earning Date
- CHCO 01-31-2025
- SLNO 03-05-2025
- Dividend Yield
- CHCO 2.64%
- SLNO N/A
- EPS Growth
- CHCO N/A
- SLNO N/A
- EPS
- CHCO 7.80
- SLNO N/A
- Revenue
- CHCO $289,546,000.00
- SLNO N/A
- Revenue This Year
- CHCO N/A
- SLNO N/A
- Revenue Next Year
- CHCO $0.38
- SLNO N/A
- P/E Ratio
- CHCO $15.35
- SLNO N/A
- Revenue Growth
- CHCO 0.71
- SLNO N/A
- 52 Week Low
- CHCO $97.50
- SLNO $36.61
- 52 Week High
- CHCO $137.28
- SLNO $60.92
- Technical
- Relative Strength Index (RSI)
- CHCO 46.41
- SLNO 50.73
- Support Level
- CHCO $117.92
- SLNO $41.50
- Resistance Level
- CHCO $121.80
- SLNO $49.03
- Average True Range (ATR)
- CHCO 2.76
- SLNO 2.31
- MACD
- CHCO 0.36
- SLNO 0.47
- Stochastic Oscillator
- CHCO 77.20
- SLNO 71.45
About CHCO City Holding Company
City Holding Co is a financial holding company. It provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, saving accounts, credit card and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance, technology products, and others. These products and services are provided to commercial banking, consumer banking, mortgage banking, wealth management, and trust services.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.